MemorialCare Deploys Abridge’s GenAI Clinical Documentation Across Enterprise

 MemorialCare Deploys Abridge’s GenAI Clinical Documentation Across Enterprise

What You Should Know: 

MemorialCare, a healthcare system in Southern California, announced today a partnership with Abridge, a company pioneering the use of generative AI for clinical documentation. 

– The strategic collaboration aims to streamline administrative tasks for physicians and improve patient care experiences.

Reducing Burden and Rekindling Human Connection

MemorialCare anticipates Abridge’s AI technology to significantly reduce the administrative burden of medical record keeping for its physicians. By automating note generation, Abridge frees up valuable time for doctors to focus on the human aspect of patient care – building rapport and providing personalized attention.

The Abridge platform integrates seamlessly into MemorialCare’s existing Epic workflow, minimizing disruptions and easing adoption for physicians. Notably, this partnership follows successful deployments of Abridge technology at numerous prestigious health systems across the US.

Early Success and Diverse Support

Physicians at MemorialCare have been piloting Abridge for several months, reporting positive experiences and a tangible reduction in documentation time. Importantly, the Abridge platform caters to MemorialCare’s diverse patient population by supporting over 50 specialties and facilitating communication in 14 languages.

A critical feature of Abridge is its “Linked Evidence” technology. This allows clinicians to easily verify any portion of the AI-generated summary by referencing the original patient conversation transcript and audio recording. This transparency builds trust and ensures the accuracy of medical records.

“Watching Abridge work in real-time sometimes feels like watching a science-fiction movie—it’s magical. It is a privilege for me to be part of the effort to bring Abridge into MemorialCare and the broader healthcare community,” said Dr. David Kim, EVP and CEO, MemorialCare Medical Foundation. “I have a bold prediction for how Abridge will impact us—⅓ of clinicians will go home sooner, ⅓ will use Abridge to sustain the strains of today’s healthcare pressures, and ⅓ will be able to see more critical patients who need timely attention.”